News &amp; Updates

Eating vegetables, fruits, fish, and plant-based foods helps enhance brain function and lower the risk of cognitive impairment and decline in Chinese populations, including those from mainland China, Hong Kong, Taiwan, and Singapore, according to a systematic review and meta-analysis.

Varenicline shows promise in vaping cessation

People who wish to quit vaping may find success with the help of varenicline, which has been found in a recent study to result in numerically higher abstinence rates relative to placebo.

Clopidogrel vs aspirin maintenance post-PCI with DES: Which reigns better?

Results from the 10-year follow-up of the HOST-EXAM* trial favour clopidogrel over aspirin as chronic maintenance therapy after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES).

CDI linked to adverse outcomes among hospitalized patients with cancer

For hospitalized cancer patients, contracting Clostridioides difficile infection (CDI) contributes to a substantial increase in mortality and healthcare resource use, according to a cross-sectional study.

Finerenone protects kidneys in patients with T1D + CKD

Finerenone significantly reduces albuminuria vs placebo and maintains a manageable safety profile in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) receiving background therapy with renin-angiotensin-aldosterone system inhibitors (RAASi), the phase III FINE-ONE trial has shown. These findings represent an important step forward since RAASi were introduced for renoprotection in T1D more than 30 years ago.

09 Apr 2026

Wearable red-light device looks good for poststroke rehabilitation

08 Apr 2026 by

A novel wearable red-light device for photobiomodulation of the brain shows promise for poststroke rehabilitation, with favourable effects on cognitive function and neuropsychiatric symptoms, as shown in a study.

C-index predicts adverse outcomes, death in anticoagulated patients with AF

The conicity index (C-index) appears to be the most robust and most consistent prognostic value among adiposity indices in anticoagulated patients with atrial fibrillation (AF), suggests a study.

Is red meat a risk factor for MASLD?

08 Apr 2026 by

High consumption of red meat appears to increase the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD), but only in men, particularly at intake levels ranging from 75 to 90 g/day, reveals a recent study.

08 Apr 2026

SGLT2 inhibitor vs GLP-1 RA: Which is better for CKD patients with diabetes?

Initiation of an SGLT2 inhibitor, relative to a GLP-1 receptor agonist (RA), results in a lower risk of adverse kidney events among patients with stage 2 diabetes and stage 4‒5 chronic kidney disease (CKD), with similar cardiovascular and mortality risks, a study has shown.